HLX11, a Proposed Pertuzumab Biosimilar: Pharmacokinetics, Immunogenicity, and Safety Profiles Compared to Three Reference Biologic Products (US-, EU-, and CN-Approved Pertuzumab)...

por Yang, Jingjing, Lin, Lili, Long, Qihe, Zhang, Qian, Sun, Guilan, Zhou, Liang, Wang, Qingyu, Zhu, Jun, Li, Fanfan, Hu, Wei
Publicado 2022

Association of HER-2/CEP17 Ratio and HER-2 Copy Number With pCR Rate in HER-2-Positive Breast Cancer After Dual-Target Neoadjuvant Therapy With Trastuzumab and Pertuzumab

por Li, Fanfan, Ju, Qian, Gao, Cong, Li, Jingjing, Wang, Xiaolei, Yan, Min, Zhang, Liying, Huang, Meiling, Long, Qihe, Jin, Xiangting, Li, Nanlin
Publicado 2022